Renaissance Technologies’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.15M | Sell |
338,441
-200,568
| -37% | -$6.74M | 0.01% | 1011 |
|
|
2025
Q4 | $23.1M | Buy |
539,009
+64,800
| +14% | +$2.44M | 0.04% | 543 |
|
|
2025
Q3 | $13.4M | Buy |
474,209
+237,763
| +101% | +$7.11M | 0.02% | 929 |
|
|
2025
Q2 | $4.43M | Buy |
236,446
+35,300
| +18% | +$669K | 0.01% | 1594 |
|
|
2025
Q1 | $3.62M | Sell |
201,146
-98,563
| -33% | -$2M | 0.01% | 1622 |
|
|
2024
Q4 | $5.04M | Buy |
299,709
+157,763
| +111% | +$3.03M | 0.01% | 1450 |
|
|
2024
Q3 | $2.3M | Sell |
141,946
-3,000
| -2% | -$35.3K | ﹤0.01% | 1929 |
|
|
2024
Q2 | $1.19M | Sell |
144,946
-57,073
| -28% | -$597K | ﹤0.01% | 2223 |
|
|
2024
Q1 | $2.99M | Buy |
202,019
+70,196
| +53% | +$946K | ﹤0.01% | 1770 |
|
|
2023
Q4 | $1.91M | Buy |
131,823
+18,640
| +16% | +$191K | ﹤0.01% | 1977 |
|
|
2023
Q3 | $1.22M | Sell |
113,183
-44,930
| -28% | -$541K | ﹤0.01% | 2166 |
|
|
2023
Q2 | $2.04M | Sell |
158,113
-39,759
| -20% | -$538K | ﹤0.01% | 1986 |
|
|
2023
Q1 | $2.61M | Buy |
197,872
+118,022
| +148% | +$1.88M | ﹤0.01% | 1861 |
|
|
2022
Q4 | $1.2M | Sell |
79,850
-50,673
| -39% | -$465K | ﹤0.01% | 2425 |
|
|
2022
Q3 | $1.54M | Buy |
130,523
+94,073
| +258% | +$1.27M | ﹤0.01% | 2212 |
|
|
2022
Q2 | $412K | Buy |
36,450
+14,810
| +68% | +$297K | ﹤0.01% | 3269 |
|
|
2022
Q1 | $647K | Buy |
21,640
+14,380
| +198% | +$389K | ﹤0.01% | 3022 |
|
|
2021
Q4 | $192K | Buy |
+7,260
| New | +$219K | ﹤0.01% | 3524 |
|
|
2021
Q2 | – | Sell |
-22,050
| Closed | -$754K | – | 3726 |
|
|
2021
Q1 | $754K | Sell |
22,050
-186,811
| -89% | -$7.4M | ﹤0.01% | 2736 |
|
|
2020
Q4 | $7.31M | Sell |
208,861
-129,180
| -38% | -$3.74M | 0.01% | 1359 |
|
|
2020
Q3 | $8.11M | Sell |
338,041
-243,727
| -42% | -$5.98M | 0.01% | 1282 |
|
|
2020
Q2 | $10.6M | Buy |
581,768
+160,856
| +38% | +$2.89M | 0.01% | 1179 |
|
|
2020
Q1 | $6.57M | Buy |
420,912
+123,218
| +41% | +$2.62M | 0.01% | 1407 |
|
|
2019
Q4 | $6.37M | Buy |
297,694
+108,230
| +57% | +$2.23M | ﹤0.01% | 1720 |
|
|
2019
Q3 | $3.54M | Buy |
189,464
+176,384
| +1,349% | +$3.64M | ﹤0.01% | 1982 |
|
|
2019
Q2 | $341K | Sell |
13,080
-49,293
| -79% | -$1.11M | ﹤0.01% | 3133 |
|
|
2019
Q1 | $1.6M | Buy |
+62,373
| New | +$1.43M | ﹤0.01% | 2431 |
|
|
2018
Q2 | – | Sell |
-68,993
| Closed | -$2.44M | – | 3480 |
|
|
2018
Q1 | $2.44M | Buy |
68,993
+4,210
| +6% | +$169K | ﹤0.01% | 2225 |
|
|
2017
Q4 | $2.51M | Buy |
64,783
+41,609
| +180% | +$1.58M | ﹤0.01% | 2209 |
|
|
2017
Q3 | $589K | Buy |
+23,174
| New | +$564K | ﹤0.01% | 2747 |
|
|
2016
Q4 | – | Sell |
-62,980
| Closed | -$2.31M | – | 3411 |
|
|
2016
Q3 | $2.31M | Sell |
62,980
-16,280
| -21% | -$467K | ﹤0.01% | 2104 |
|
|
2016
Q2 | $1.77M | Buy |
79,260
+13,180
| +20% | +$328K | ﹤0.01% | 2266 |
|
|
2016
Q1 | $1.37M | Buy |
66,080
+16,120
| +32% | +$398K | ﹤0.01% | 2427 |
|
|
2015
Q4 | $1.51M | Buy |
49,960
+10,100
| +25% | +$306K | ﹤0.01% | 2276 |
|
|
2015
Q3 | $985K | Buy |
39,860
+14,460
| +57% | +$432K | ﹤0.01% | 2392 |
|
|
2015
Q2 | $815K | Buy |
25,400
+15,310
| +152% | +$585K | ﹤0.01% | 2548 |
|
|
2015
Q1 | $360K | Sell |
10,090
-41,583
| -80% | -$1.14M | ﹤0.01% | 2702 |
|
|
2014
Q4 | $1.17M | Sell |
51,673
-7,260
| -12% | -$147K | ﹤0.01% | 2059 |
|
|
2014
Q3 | $1.14M | Buy |
58,933
+16,808
| +40% | +$475K | ﹤0.01% | 1961 |
|
|
2014
Q2 | $1.53M | Buy |
42,125
+21,072
| +100% | +$716K | ﹤0.01% | 1863 |
|
|
2014
Q1 | $817K | Sell |
21,053
-93,961
| -82% | -$3.35M | ﹤0.01% | 2165 |
|
|
2013
Q4 | $3.28M | Buy |
115,014
+69,480
| +153% | +$2.04M | 0.01% | 1454 |
|
|
2013
Q3 | $1.63M | Buy |
45,534
+437
| +1% | +$15.9K | ﹤0.01% | 1771 |
|
|
2013
Q2 | $1.51M | Buy |
+45,097
| New | +$2.04M | ﹤0.01% | 1735 |
|
Other funds holding RIGL
AC
VCM
Renaissance Technologies's RIGL Position: Q1 2026 in Review
Renaissance Technologies reduced its Rigel Pharmaceuticals (RIGL) stake by 37% in Q1 2026, selling an estimated $6.74M and leaving 338,441 shares worth $9.15M. The position accounts for 0.01% of the portfolio, ranked #1011.
Renaissance Technologies first reported a position in RIGL in Q2 2013 and has held it in 44 quarters since. The position peaked at $23.1M in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.
- Renaissance Technologies held 338,441 shares of Rigel Pharmaceuticals worth $9.15M as of Q1 2026.
- Renaissance Technologies sold 200,568 Rigel Pharmaceuticals shares in Q1 2026, an estimated $6.74M.
- Rigel Pharmaceuticals made up 0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1011 holding.
- Renaissance Technologies first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
- Renaissance Technologies's Rigel Pharmaceuticals position peaked at $23.1M in Q4 2025.
- 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.